Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 USD | +1.97% | +9.54% | -34.84% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.84% | 824M | |
-2.08% | 103B | |
+1.97% | 95.28B | |
+2.65% | 22.15B | |
-15.87% | 21.02B | |
-8.77% | 18.15B | |
-41.01% | 16.73B | |
-13.82% | 16.05B | |
+3.47% | 13.68B | |
+33.58% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04